California BanCorp \ CA vs Capital Bancorp
BCAL and CBNK side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BCAL and CBNK compare
California BanCorp \ CA and Capital Bancorp are about the same size, with market caps of $691M and $680M.
On earnings, California BanCorp \ CA is cheaper: it trades at 11.7× trailing earnings, against 12.3× for Capital Bancorp.
Capital Bancorp grew revenue faster over the last twelve months (15.1% versus 4.3% for California BanCorp \ CA).
California BanCorp \ CA keeps more of each dollar of sales as profit, with a net margin of 33.4% compared with 22.2% at Capital Bancorp.
Both pay dividends: California BanCorp \ CA yields 2.0% and Capital Bancorp 1.2%.
Capital Bancorp scores higher on the StockData Score (16 against 14 for California BanCorp \ CA), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BCAL | CBNK |
|---|---|---|
| Size and price | ||
| Market cap | $691M | $680M |
| Share price | $21.48 | $41.72 |
| Change, 1 year | 18.7% | 49.6% |
| Change, 5 years | 38.8% | 51.2% |
| Beta (5Y) | 0.42 | 0.62 |
| Employees | 288 | 459 |
| StockData Score | ||
| Total score | 14 | 16 (better) |
| Valuation score | 3 (better) | 2 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 | 4 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 11.7× (better) | 12.3× |
| P/S | 3.8× | 2.7× (better) |
| P/B | 1.2× (better) | 1.6× |
| P/FCF | 11.7× | – |
| PEG | 0.39 (better) | 2.26 |
| FCF yield | 8.6% | – |
| Fair value | $21.70 | $35.14 |
| Margin of safety | 1.0% (better) | −18.7% |
| Growth | ||
| Revenue growth (TTM) | 4.3% | 15.1% (better) |
| Revenue growth, 5Y average | – | 12.8% |
| Net income growth (TTM) | 92.6% (better) | 30.3% |
| EPS growth (TTM) | 114% (better) | 27.3% |
| EPS growth, 5Y average | – | 12.8% |
| Profitability | ||
| Net margin | 33.4% (better) | 22.2% |
| FCF margin | 32.9% | – |
| Return on equity | 10.6% | 14.1% (better) |
| Financial health | ||
| Altman Z-score | 0.22 | 0.30 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.0% (better) | 1.2% |
| Payout ratio | – | 14.0% |
| Years of dividend growth | – | 4 |
| Buyback yield | 1.8% (better) | 1.7% |
| Shareholder yield | 3.8% (better) | 2.9% |
| Ownership | ||
| Held by institutions | 71.0% | 45.4% |
| Held by insiders | 8.6% | 25.5% |
| Insider net buying, 12 months | −$46.0M | −$95.0K (better) |
| Short interest, % of float | 3.4% | 5.5% |
Go deeper
- BCAL stock overview
- BCAL income statement
- BCAL valuation and score
- CBNK stock overview
- CBNK income statement
- CBNK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.